Rafael Holdings was spun-off from IDT Corporation and listed on the NYSE American exchange earlier this year.
“We are delighted to celebrate the spin-off and listing of Rafael Holdings by ringing the NYSE Opening Bell,” said Mr. Jonas. “Since the spin-off, the Company has been pursuing strategies to realize the value of our real estate and pharma holdings and we are excited about our long-term prospects.”
About Rafael Holdings, Inc.:
Rafael Holdings holds commercial real estate assets and interests in two clinical stage pharmaceutical companies. The real estate holdings consist of properties in Newark and Piscataway, New Jersey and Jerusalem, Israel. The pharmaceutical holdings consist of interests in Rafael Pharmaceuticals, Inc. and a majority stake in Lipomedix Pharmaceuticals Ltd. Both are focused on development and commercialization of drugs in the oncology space. For more information, visit www.rafaelholdings.com.
SOURCE Rafael Holdings, Inc.